Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. ...Middle East

HANGZHOU, China, June 14, 2024 /PRNewswire/ -- Venus Medtech (02500. HK), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced today that its in-house developed innovative transcatheter pulmonic valve replacement (TPVR)...

Read More Details
Finally We wish PressBee provided you with enough information of ( Venus Medtech VenusP-Valve Completed First Implantation in IDE Pivotal Clinical Study in U.S. )

Also on site :

• Could 100 Men Really Take on One Gorilla and Win? We Asked ChatGPT
• Trump sees no red line that would change tariff policy - The Atlantic
• Pope Tawadros meets with mayor of Polish town